Citation Impact
Citing Papers
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status
2020 Standout
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
COVID-19: A promising cure for the global panic
2020 Standout
Valganciclovir in Adult Solid Organ Transplant Recipients
2009
Ganciclovir
2018
Lung and heart-lung transplantation in children
1997
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Cytomegalovirus Infection Following Liver Transplantation: Review of the Literature
1996
Prophylaxis against Opportunistic Infections in Patients with Human Immunodeficiency Virus Infection
2000
Oral valganciclovir as preemptive therapy for cytomegalovirus infection post allogeneic stem cell transplantation
2007
Oral Ganciclovir for Patients with Cytomegalovirus Retinitis Treated with a Ganciclovir Implant
1999
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
Assessment of Cytomegalovirus Hybrid Preventative Strategy in Pediatric Heart Transplant Patients
2012
Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients
1997
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Drug Compliance in Therapeutic Trials
1998
Infection in Solid-Organ Transplant Recipients
2007 Standout
A meta-analysis of the association between adherence to drug therapy and mortality
2006 Standout
Antiviral Drugs for Viruses Other Than Human Immunodeficiency Virus
2011
Kaposi's Sarcoma
2000 Standout
Pharmaceutical and therapeutic Potentials of essential oils and their individual volatile constituents: a review
2007 Standout
Infection in Organ-Transplant Recipients
1998 Standout
Plasma exchange for Alzheimer's disease Management by Albumin Replacement (AMBAR) trial: Study design and progress
2019
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
2009
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
New Antiherpesvirus Agents
1996
Guidelines for Preventing Opportunistic Infections among HIV-Infected Persons—2002: Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America*
2002
Valganciclovir Results in Improved Oral Absorption of Ganciclovir in Liver Transplant Recipients
2000
Update on Human Herpesvirus 6 Biology, Clinical Features, and Therapy
2005
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Infection after lung transplantation.
1993
Works of Anna Shadman being referenced
Pharmacokinetic, Safety, and Antiviral Profiles of Oral Ganciclovir in Persons Infected with Human Immunodeficiency Virus: A Phase I/II Study
1995
Oral Ganciclovir as Maintenance Treatment for Cytomegalovirus Retinitis in Patients with AIDS
1995
A RANDOMIZED, DOUBLE-BLIND, PHASE 2 STUDY OF THE EFFECTS OF THE VACCINE VANUTIDE CRIDIFICAR WITH QS-21 ADJUVANT ON IMMUNOGENICITY, SAFETY AND AMYLOID IMAGING IN PATIENTS WITH MILD TO MODERATE ALZHEIMER’S DISEASE
2016
Cytomegalovirus (CMV) Resistance in Patients with CMV Retinitis and AIDS Treated with Oral or Intravenous Ganciclovir
1999